ZA901121B - 2-amino-7-hydroxytetralin carboxyalkyl ethers - Google Patents

2-amino-7-hydroxytetralin carboxyalkyl ethers

Info

Publication number
ZA901121B
ZA901121B ZA901121A ZA901121A ZA901121B ZA 901121 B ZA901121 B ZA 901121B ZA 901121 A ZA901121 A ZA 901121A ZA 901121 A ZA901121 A ZA 901121A ZA 901121 B ZA901121 B ZA 901121B
Authority
ZA
South Africa
Prior art keywords
amino
carboxyalkyl ethers
hydroxytetralin
phenylethanolaminotetralins
xii
Prior art date
Application number
ZA901121A
Inventor
Umberto Guzzi
Guzzi Umberto
Roberto Cecchi
Cecchi Roberto
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA901121B publication Critical patent/ZA901121B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to 2-amino-7-hydroxytetralin carboxyalkyl ethers of formula <IMAGE> in which Alk represents a straight- or branched-chain alkylene group having 3 to 5 carbon atoms and R is hydrogen or a C1-C4 alkyl group, which are useful as starting materials in the synthesis of 7-substituted phenylethanolaminotetralins of formula (XII) <IMAGE> in which X represents hydrogen, halogen or a C1-C4 alkyl or trifluoromethyl group, having spasmolytic activity. The new 7-substituted phenylethanolaminotetralins (XII) as well as the intermediates in the preparation of the compounds (I), the N-protected 2-amino-7-hydroxytetralin carboxyalkyl ethers, are also claimed.
ZA901121A 1989-02-14 1990-02-14 2-amino-7-hydroxytetralin carboxyalkyl ethers ZA901121B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8901910A FR2643076B1 (en) 1989-02-14 1989-02-14 CARBOXYALKYL-ETHERS OF 2-AMINO-7-HYDROXYTETRALINE

Publications (1)

Publication Number Publication Date
ZA901121B true ZA901121B (en) 1990-11-28

Family

ID=9378776

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901121A ZA901121B (en) 1989-02-14 1990-02-14 2-amino-7-hydroxytetralin carboxyalkyl ethers

Country Status (13)

Country Link
EP (1) EP0383686B1 (en)
JP (1) JP2852681B2 (en)
AT (1) ATE92470T1 (en)
AU (1) AU642402B2 (en)
CA (1) CA2009992A1 (en)
DE (1) DE69002474T2 (en)
DK (1) DK0383686T3 (en)
ES (1) ES2060079T3 (en)
FR (1) FR2643076B1 (en)
IE (1) IE61811B1 (en)
NZ (1) NZ232543A (en)
PT (1) PT93126B (en)
ZA (1) ZA901121B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669821A1 (en) * 1990-12-04 1992-06-05 Sanofi Sa USE OF PHENYLETHANOLAMINOTETRALINES FOR THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF LOW PRESSURE.
EP0499755A1 (en) * 1991-02-18 1992-08-26 MIDY S.p.A. Phenylethanolaminotetralines, process for their preparation, intermediates of this process and pharmaceutical compositions containing them
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
DE69331783T2 (en) * 1992-01-22 2002-11-21 Glaxo Group Ltd., Greenford Medical use of atypical beta adrenoceptor agonists
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1997005091A1 (en) * 1995-07-26 1997-02-13 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and drugs comprising the same as active ingredients
WO1997015549A1 (en) * 1995-10-26 1997-05-01 Tokyo Tanabe Company Limited PHENYLETHANOLAMINE COMPOUNDS USEFUL AS β3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME
JP3708624B2 (en) * 1996-03-27 2005-10-19 キッセイ薬品工業株式会社 3,4-disubstituted phenylethanolaminotetralin carboxylic acid derivative
AUPO565997A0 (en) * 1997-03-17 1997-04-10 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
FR2826651B1 (en) * 2001-06-28 2005-09-02 Sanofi Synthelabo CRYSTALLINE FORM OF PHENYLETHANOLAMINE, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
JP2007503362A (en) * 2003-08-25 2007-02-22 シモネク,ミロスラフ Wrapping paper for chewing gum after chewing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3623941A1 (en) * 1986-07-16 1988-01-28 Bayer Ag SUBSTITUTED AMINO-5,6,7,8-TETRAHYDRONAPHTHYL OXYACETIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
EP0383686B1 (en) 1993-08-04
IE900509L (en) 1990-08-14
JPH0314548A (en) 1991-01-23
NZ232543A (en) 1992-07-28
PT93126A (en) 1990-08-31
EP0383686A1 (en) 1990-08-22
IE61811B1 (en) 1994-11-30
PT93126B (en) 1995-12-29
CA2009992A1 (en) 1990-08-14
ATE92470T1 (en) 1993-08-15
DE69002474D1 (en) 1993-09-09
DK0383686T3 (en) 1993-12-20
FR2643076B1 (en) 1991-06-21
AU642402B2 (en) 1993-10-21
JP2852681B2 (en) 1999-02-03
ES2060079T3 (en) 1994-11-16
DE69002474T2 (en) 1994-03-10
AU4978690A (en) 1990-08-23
FR2643076A1 (en) 1990-08-17

Similar Documents

Publication Publication Date Title
DE3368053D1 (en) Substituated 1-hydroxy-ethyl-triazolyl derivatives
PH20768A (en) New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof
ES8306142A1 (en) Substituted N-(4-indolyl-piperidino-alkyl) benzimidazolones, processes for their preparation and their use as pharmaceutical preparations.
DE69002474D1 (en) Carboxyalkyl-ether von 2-amino-7-hydroxytetralin.
ES8505518A1 (en) Amino-acids derivatives, process for their preparation and their use.
ES8507090A1 (en) 1,5-Benzothiazepines with cardiovascular utility, and pharmaceutical compositions containing them
DE3477782D1 (en) Imidazo(1,2-c)pyrimidines and their salts, process for their preparation, their use as medicaments and compositions containing them
EP0257572A3 (en) Thyronin derivatives
ES8607967A1 (en) Thiazolylacetic acid derivatives and their preparation.
DE3564426D1 (en) Polyprenyl compound, process of producing it and pharmaceutical use
GR3006223T3 (en)
ES8607944A1 (en) Derivatives of 1-phenylimidazolidin-2-one, their preparation and their application.
ES8602620A1 (en) Omega- not (2-hydroxy-4-phenyl)methylene-amino -phenyl-alkanecarboxylic acids, their preparation and therapeutical use
ES2009283A6 (en) Aminoacylates of glycerol acetal